TMX Newsfile

IN THE PRESS

Business

EVP Capital Announces Agreement for Proposed Qualifying Transaction

July 2, 2024

·

26 min read

Policy

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24

June 4, 2024

·

1 min read

Awakn Life Sciences Announces Closing of Tranche of Private Placement

June 4, 2024

·

4 min read

Drug Development

Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise

June 3, 2024

·

6 min read

Scryb Announces Closing of Private Placement

June 3, 2024

·

4 min read

Scryb Applauds New Bipartisan $32B Roadmap for AI Policy from U.S. Senate; Driving the Market for Scryb’s AI Compliance Solution

June 3, 2024

·

5 min read

Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments

June 3, 2024

·

10 min read

Pharm Country

Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune’s TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications

May 30, 2024

·

8 min read

Telo Genomics Announces Publication of Results from Its Smoldering Myeloma Clinical Study in the American Journal of Hematology

May 30, 2024

·

6 min read

BioHarvest Sciences Reports First Quarter 2024 Financial Results

May 30, 2024

·

10 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750